Professor Lloyd Sansom

Emeritus Professor UniSA Clinical & Health Sciences

City West Campus ()

email Lloyd.Sansom@unisa.edu.au

Available for media comment

Research

Research focus

Public Health and Health Services
Environmental Sciences
Applied Economics
Chair
Medical and Health Sciences

Research

Outputs

Research outputs for the last seven years are shown below.

Open access indicates that an output is open access.

Journal Articles

Year	Output
2021	Howe, K, Bourke, S & Sansom, L 2021, 'The extent to which off-patent registered prescription medicines are used for off-label indications in Australia: a scoping review', PLoS One, vol. 16, no. 12, article no. e0261022, pp. 1-17. Open access 1 1
2021	Latimer, NR, Pollard, D, Towse, A, Henshall, C, Sansom, L, Ward, RL, Bruce, A & Deakin, C 2021, 'Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi‐stakeholder, international workshop', BMC Health Services Research, vol. 21, no. 1, article no. 412, pp. 1-9. Open access 6 4 2
2017	Wale, J, Scott, AM, Hofmann, B, Garner, S, Low, E & Sansom, L 2017, 'Why patients should be involved in health technology assessment', International Journal of Technology Assessment in Health Care, vol. 33, no. 1, pp. 1-4. Open access 27 23 39
2016	Henshall, C, Latimer, NR, Sansom, LN & Ward, RL 2016, 'Treatment switching in cancer trials: Issues and proposals', International Journal of Technology Assessment in Health Care, vol. 32, no. 3, pp. 167-174. Open access 16 16 1
2014	Henshall, C, Sansom, LN, Eichler, H-G, Lembruger, A, Longson, C, O'Rourke, B & Tunis, S 2014, 'Understanding the role and evidence expectations of health technology assessment and coverage/payer bodies: What are they looking for, and how and why does this differ from what regulators require?', Therapeutic Innovation and Regulatory Science, vol. 48, no. 3, pp. 341-346. 7 7 10
2013	Juhasz, AL, Smith, ERG, Weber, J, Rees, M, Kuchel, T, Rofe, A, Sansom, LN & Naidu, R 2013, 'Predicting lead relative bioavailability in peri-urban contaminated soils using in vitro bioaccessibility assays', Journal of Environmental Science and Health - Part A Toxic/Hazardous Substances and Environmental Engineering, vol. 48, no. 6, pp. 604-611. 31 29 1
2010	Sansom, LN 2010, 'Assessing the value of medicines', Pharmaceutical Medicine, vol. 24, no. 2, pp. 89-92. 2
2009	Juhasz, AL, Weber, J, Smith, E, Naidu, R, Marschner, B, Rees, M, Rofe, A, Kuchel, T & Sansom, L 2009, 'Evaluation of SBRC-Gastric and SBRC-Intestinal methods for the prediction of in vivo relative lead bioavailability in contaminated soils', Environmental Science and Technology, vol. 43, no. 12, pp. 4503-4509. 103 95
2009	Juhasz, AL, Weber, J, Smith, E, Naidu, R, Rees, M, Rofe, A, Kuchel, T & Sansom, L 2009, 'Assessment of four commonly employed in vitro arsenic bioaccessibility assays for predicting in vivo relative arsenic bioavailability in contaminated soils', Environmental Science and Technology, vol. 43, no. 24, pp. 9487-9494. 145 132
2009	Rahman, MM, Rahman, F, Sansom, L, Naidu, R & Schmidt, O 2009, 'Arsenic interactions with lipid particles containing iron', Environmental Geochemistry and Health: Official Journal of the Society for Environmental Geochemistry and Health, vol. 31, no. s1, pp. 201-206. 11 10
2009	Rees, M, Sansom, L, Rofe, A, Juhasz, AL, Smith, E, Weber, J, Naidu, R & Kuchel, T 2009, 'Principles and application of an in vivo swine assay for the determination of arsenic bioavailability in contaminated matrices', Environmental Geochemistry and Health: Official Journal of the Society for Environmental Geochemistry and Health, vol. 31, s1, pp. 167-177. 46 42
2008	Juhasz, AL, Smith, ERG, Weber, J, Naidu, R, Rees, M, Rofe, A, Kuchel, T & Sansom, LN 2008, 'Application of an In Vivo Swine Model for the Determination of Arsenic Bioavailability in Hydroponically-Grown Vegetables', Chemosphere, vol. 71, no. 10, pp. 1963-1969. 49 45
2008	Juhasz, AL, Smith, ERG, Weber, J, Naidu, R, Rees, M, Rofe, A, Kuchel, T & Sansom, LN 2008, 'Effect of Soil Ageing on In Vivo Arsenic Bioavailability in Two Dissimilar Soils', Chemosphere, vol. 71, no. 11, pp. 2180-2186. 58 55

External engagement & recognition

Collaborations

External engagement & recognition

Collaborations

Organisation	Country
Amgen (Australia)	AUSTRALIA
Australian National University	AUSTRALIA
Bond University	AUSTRALIA
Brunel University	UNITED KINGDOM
Brunel University London	UNITED KINGDOM
Canadian Agency for Drugs and Technologies in Health	CANADA
Center for Medical Technology Policy	UNITED STATES
European Medicines Agency	NETHERLANDS
Health Technology Assessment International (HTAi)	CANADA
Institute of Medical and Veterinary Science	AUSTRALIA
Myeloma UK	UNITED KINGDOM
National Institute for Health and Care Excellence	UNITED KINGDOM
National Institute for Health and Care Excellence (NICE)	UNITED STATES
Office of Health Economics	UNITED KINGDOM
Pan American Health Organization	CUBA
Ruhr University Bochum	GERMANY
SA Pathology	AUSTRALIA
South Australian Health and Medical Research Institute (SAHMRI)	AUSTRALIA
University of Adelaide	AUSTRALIA
University of Oslo	NORWAY
University of Queensland	AUSTRALIA
University of Sheffield	UNITED KINGDOM
University of South Australia	AUSTRALIA
University of Sydney	AUSTRALIA

External engagement & recognition

Engagement/recognition	Year
Andre Bedat Award International Pharmaceutical Association	2018

more less

Professor Lloyd Sansom

About me

About me

UniSA Clinical & Health Sciences

About me

Professional Associations

Experience

Qualifications

Research

Research focus

Projects

Outputs

Journal Articles

External engagement & recognition

Collaborations

Collaborations

External engagement & recognition

Andre Bedat Award

Gallery